Thus targeting CAV1-dependent HSP27 signaling potentially by SRC kinase inhibition represents a promising (androgen receptor disrupting) therapeutic strategy to limit PCa progression and moreover to sensitize PCa to RT. The gene discussed is AR; the disease is posterior cortical atrophy.